Want to see XLO full AI Analyst Report?

Xilio Therapeutics (XLO) Revenue

218 Followers

Xilio Therapeutics Revenue

Xilio Therapeutics had a revenue of 18.69M in the quarter ending Jun 30, 2026, with 47.79%. This bring the company's revenue in the last twelve months to 64.09M, Decreased 19.83%. In the fiscal year ending Dec 31, 2025, Xilio Therapeutics had annual revenue of 43.77M with 589.88% growth.

Revenue (ttm)

64.09M

Revenue Growth

327.25%

P/S Ratio

1.35

Revenue/Employee

$575,868

Employees

Market Cap

$59.09M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	43.77M	37.42M	+589.88%
Dec 31, 2024	6.34M	―	+∞%
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―